# Intranasal AD4-H5-VTN as an Adenovirus Vaccine

> **NCT01806909** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 51 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **BIOLOGICAL:** Ad4-H5-Vtn

## Key facts

- **NCT ID:** NCT01806909
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-06
- **Primary completion:** 2018-01-09
- **Final completion:** 2019-04-22
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01806909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01806909, "Intranasal AD4-H5-VTN as an Adenovirus Vaccine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01806909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*